Clinical trial · Observational
Fluciclovine PET/CT in Multiple Myeloma Patients
PET i Diagnostikk og Behandlingsrespons av Pasienter Med Myelomatose
NCT03966443CI-TRIAL-00038847FLUCIPETrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Comparison between image findings at aminoacid PET/CT and FDG PET/CT for myeloma patients
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Myeloma, Multiple | Multiple Myeloma | CURATED_EXACT | 0.92 |
| PET-CT | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Comparing of image findings at PET
- timeFrame
- 1 year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Multiple myeloma patients suitable for ASCT treatment Exclusion Criteria: * Patients with contraindications to ASCT treatment
References
Publications (0)
Data not yet available
No reference posted for this study.